Exchange: NASDAQ·Updated 07:44 PM EST
IRON logo

IRON Disc Medicine Inc

$75.39
$0.97
(1.27%)
Today
Closed $75.14
$0.25
(0.33%)
After Hours
Reported EarningsNov 5
Mkt Cap$3.42B
Vol561,645.00

About IRON

Disc Medicine, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery, development, and commercialization of treatments for hematologic diseases. It assembles a portfolio of clinical and preclinical product candidates that aim to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. The company was founded in October 2017 and is headquartered in Watertown, MA.
46

Neutral Sentiment

How do you feel about IRON?

BiotechSwings
December is doing the talking for $IRON imo ASH Dec 12 to 15 brings fresh DISC 3405 data, updated RESTORE PV in polycythemia vera plus first sickle cell data. bitopertin already cleared its big test, APOLLO hit every endpoint in October, PPIX down 41.4% vs placebo in 183 patients, and the NDA goes back in by year end Q3 beat this morning, minus 1.53 vs minus 1.63 expected, and the stock still closed near 78.47, down about 6% on a day the sector bled about 7%
S_Franconi
$IRON Disc Medicine Announces Multiple Presentations Across Portfolio at the 68th American Society of Hematology (ASH) Annual Meeting
Merlintrader
$IRON — Large holder cuts stake to 6.6% from 8.0% in new 13D/A. Information only — not investment advice. More details in our hub.

Advertisement|Remove ads.